Navigation Links
Transport Pharmaceuticals Receives Coveted Frost & Sullivan Technology Innovation Award
Date:12/6/2007

ing to see the recognition for our innovation which is expected to bring significant contributions to patients afflicted with dermatology diseases and the physicians who treat them."

"Electrokinetic drug delivery has emerged as an alternative approach to overcome the limitations of, and to obviate the need for, hypodermic injection of many medications," said Pramodh Ishwarakrishnan, Frost & Sullivan Industry Analyst. "Transport Pharmaceuticals has achieved the noble distinction of creating a system which is poised to revolutionize the field of dermal drug delivery."

The Challenges and Promise of Transdermal Delivery

The outer layer of the skin, known as the stratum corneum, is a highly effective, impermeable barrier that serves as the immune system's natural first-line of defense. The stratum corneum prevents xenobiotics, external molecules or microorganisms from entering the body. It is this same barrier function that prevents topically applied drugs from reaching their target tissue in efficacious quantities.

The promise of Transport's technology lies in its ability to deliver a safe and effective therapeutic depot, directly in the affected tissue. The key advantages of this are two-fold; a high dose of potent drug rapidly and painlessly reaches the affected dermal tissue, while the patient avoids the potential toxicity and adverse effects associated with systemic exposure to a drug intended to act only on the skin. Transport's technology enhances both the delivery of topically applied drugs and the utility of potent, systemically delivered drugs, whose uses are limited by bioavailability, toxicity or side-effect concerns. While Transport's initial focus is herpes labialis, future indications include, onychomycosis, acne, actinic keratosis, keloids, warts, psoriasis, skin cancer and medical aesthetic applications.

About Best Practices

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and g
'/>"/>

SOURCE Transport Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. International Isotopes Inc. Announces Completion of an Exclusive Distributor Agreement for Sales of New Style Transportation Containers
2. Bioscrypts V-Station MIFARE Placed on Transportation Security Administrations Qualified Products List
3. Mechanism for the in-vivo transport of siRNA
4. AG Mednet Selected By Massachusetts General Hospital to Transport 3D Post-Processing Images
5. Reverse Cholesterol Transport by RVX-208 a Small Molecule for ApoA-I Production Increase Presented at American Heart Association Scientific Meeting
6. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
7. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Pearl's Premium Ultra Low Maintenance Lawn Seed ... seed this week with the release of their Pearl's ... the fact that it is time to plant now ... , As of the date 6/4/13, Pearl's Premium had ... experts and the media including: The National Gardeners ...
(Date:9/22/2014)... job it is to stop bleeding, are very simple. ... "feel" the physical environment around them, researchers at Emory ... surfaces with greater stiffness by increasing their stickiness, the ... other components of the clotting system, the researchers found. ... for, in that they are able to sense the ...
(Date:9/22/2014)... to create a highly sensitive chemical sensor based on ... unique electronic properties that the researchers were able to ... 300 times. , The study is available online in ... Amin Salehi- Khojin, asst professor of mechanical and industrial ... and Bijandra Kumar, post doc where they are doing ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 Topical BioMedics, ... those in pain end their suffering, restoring hope an ... model. This is only possible because of the innovative ... healing cream technology a reality. , The company ... NY, by Lou Paradise (president, chief of research, and ...
Breaking Biology Technology:Pearl's Premium Ultra Low Maintenance Lawn Seed Announces A Major Breakthrough In Drought Tolerant Grass Seed 2Platelets modulate clotting behavior by 'feeling' their surroundings 2Graphene imperfections key to creating hypersensitive 'electronic nose' 2Topical BioMedics (Topricin) Celebrates 20 Years of Providing Hope and Quality of Life...As Topricin Is Declared “The 21st Century Standard of Care for Pain Management” 2Topical BioMedics (Topricin) Celebrates 20 Years of Providing Hope and Quality of Life...As Topricin Is Declared “The 21st Century Standard of Care for Pain Management” 3Topical BioMedics (Topricin) Celebrates 20 Years of Providing Hope and Quality of Life...As Topricin Is Declared “The 21st Century Standard of Care for Pain Management” 4Topical BioMedics (Topricin) Celebrates 20 Years of Providing Hope and Quality of Life...As Topricin Is Declared “The 21st Century Standard of Care for Pain Management” 5Topical BioMedics (Topricin) Celebrates 20 Years of Providing Hope and Quality of Life...As Topricin Is Declared “The 21st Century Standard of Care for Pain Management” 6
... West Central Wisconsin Workforce Resource is inviting representatives ... Synergy Conference titled "Positioning for Economic Growth." , ,The conference ... a.m. to 5 p.m. and Sept. 21 from 8 a.m. ... Memorial Student Center . , ,Although some speakers have ...
... - Mithridion, Inc. , a biopharmaceutical startup that is ... secured $296,800 in federal grants to evaluate tests for drug ... Institute on Aging , a branch of the U.S. ... the feasibility of the tests. If successful, the company will ...
... Wis. - The recent decision by a young researcher ... some of the financial consequences of the same-sex union debate ... and nanotechnology researcher, has won $3.4 million in grants since ... year, he will take his knowledge and research with him ...
Cached Biology Technology:Conference to address small town development 2Mithridion wins grants for Alzheimer's research 2Mithridion wins grants for Alzheimer's research 3Departure of nanotech researcher stings UW 2Departure of nanotech researcher stings UW 3
(Date:9/21/2014)... to what was previously thought, newborn immune T cells ... to bacteria, according to a new study led by ... differently to that of adults, babies may still be ... study published in the journal Nature Medicine . ... different types of immune cells, including neutrophils which play ...
(Date:9/19/2014)... today by researchers from several Harvard University labs ... experienced and aspiring researchers with the intellectual raw ... made from soft, flexible materials. , With the ... other advances in manufacturing technology, soft robotics is ... drawn from conventional rigid robot design, but working ...
(Date:9/19/2014)... Imagine you are a species which over thousands of years ... exposed to a substance that makes the cold dangerous for ... Enchytraeus albidus , and the cold provoking substance, called ... cosmetics. , Nonylphenol is suspected of being a endocrine disruptor, ... It inhibits the worm,s ability to protect the cells in ...
Breaking Biology News(10 mins):Immune system of newborn babies is stronger than previously thought 2Soft robotics 'toolkit' features everything a robot-maker needs 2Environmental pollutants make worms susceptible to cold 2Environmental pollutants make worms susceptible to cold 3
... were not the only ones with visions of sugar plums ... a new research report published in the January 2010 issue ... ), a team of scientists from the University of Texas ... compound from licorice root (glycyrrhizin from Glycyrrhiza glabra ) ...
... DALLAS Jan. 4, 2010 An experimental drug currently ... fighting the brain cancer glioblastoma and prostate cancer, researchers at ... The drug,s actions, observed in isolated human cells in ... encouraging because they attacked not only the bulk of the ...
... origin of the Devil Facial Tumour Disease (DFTD) that has ... scientists has discovered. Devil Facial Tumour Disease (DFTD) ... was first reported in 1996. It is spread by biting ... large tumours, mostly on the face and mouth, which often ...
Cached Biology News:A trip to the candy store might help ward off rare, but deadly infections 2Experimental drug shows promise against brain, prostate cancers 2Nervous culprit found for Tassie devil facial tumor disease 2
Rabbit polyclonal to Shigella (HRP) ( Abpromise for all tested applications)....
... PhosphoPlus™ SAPK/JNK (Thr183/Tyr185) Antibody Kit ... (Thr183/Tyr185) Antibody, Catalog #9251, 200 ul ... 200 ul SAPK/JNK Cell Extracts, Catalog ... HRP-linked Antibody, Catalog #7074, 100 ul ...
Anti-gp120/160(SIV/mac239) Immunogen: gp120(SIV/mac239) protein (Genebank accession #M33262)...
Annexin V Binding Buffer, 10X Concentrate Buffer , 50 ml Consult technical datasheet for details....
Biology Products: